A new report from the National Academies of Sciences, Engineering, and Medicine recommends two frameworks that medical professional societies, health care organizations, and state, national and local agencies could use to develop clinical practice guidelines for prescribing opioids to manage acute pain. Requested by the Food and Drug Administration, the report also identifies surgical procedures and acute medical conditions for which evidence-based guidelines would be desirable. Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research, said the agency will consider the recommendations as it develops evidence-based prescribing guidelines for treating acute pain in therapeutic areas for which guidelines do not exist.

Related News Articles

Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Perspective
Public
The 2025 AHA Leadership Summit wrapped up on July 22, and as always, it was energizing and inspiring to connect with so many talented and dedicated people…
Headline
The AHA July 24 announced it is collaborating with health care technology leader Epic to help hospitals adopt tools that support the early detection and…
Headline
Carolyn Bogard, DNP, R.N., director of care coordination and palliative care at El Camino Health, talks about her system’s use of data to harness the passion…
Headline
Hartford HealthCare in Hartford, Conn., will receive the 2025 AHA Quest for Quality Prize as a result of their sweeping transformation over the past decade —…
Headline
A Q&A in the July edition of AHA Trustee Insights features leaders from Winchester Hospital in Massachusetts discussing the importance of board members…